×
Site Menu
Everything
International Coverage
Legalization
Local Collectives
Investing
Mental Health
Recreation
Mushroom Culture
New Tech
Publications
Mushroom Science
Physical Benefits
Hypha Labs pivots to psilocybin with new mushroom tech
DEA resists permitting psilocybin for terminal patients under ‘Right to Try’
MDMA producer PharmAla issues 4.1M new shares to raise $750,000
Maine lawmakers pass bill to study psychedelic regulation
Clearmind signs agreement with Hebrew University for psychedelic compound rights
Numinus reports declining revenue as the company restructures
Filament’s pivots pay off, nets $2.1M revenue in 2023
MindMed taps out of Cboe
Algernon sells Ifenprodil, zooms in on DMT for stroke care
Compass Pathways co-founders exit to pursue ‘broader goals’
Latest
Hypha Labs pivots to psilocybin with new mushroom tech
15 hours ago
3
DEA resists permitting psilocybin for terminal patients under ‘Right t...
20 hours ago
5
MDMA producer PharmAla issues 4.1M new shares to raise $750,000
1 day ago
7
Maine lawmakers pass bill to study psychedelic regulation
5 days ago
15
Clearmind signs agreement with Hebrew University for psychedelic compo...
5 days ago
11
Numinus reports declining revenue as the company restructures
1 week ago
20
Filament’s pivots pay off, nets $2.1M revenue in 2023
2 weeks ago
23
MindMed taps out of Cboe
3 weeks ago
15
Algernon sells Ifenprodil, zooms in on DMT for stroke care
3 weeks ago
31
Compass Pathways co-founders exit to pursue ‘broader goals’
3 weeks ago
34
Atai cash purse down nearly half despite lower spending
3 weeks ago
34
Atai nasal spray hits mark in depression study
3 weeks ago
25
Alto Neuroscience is enjoying a solid cash cushion
4 weeks ago
26
Enveric Biosciences pins hopes on licensing deals
4 weeks ago
32
Psychedelic therapy program to launch in Utah
4 weeks ago
29
Relmada Therapeutics trims losses, slashes research costs
1 month ago
21
Seelos Therapeutics swings and misses on ALS drug study
1 month ago
21
Swedish study looks at psychedelic treatments for teens with psychotic...
1 month ago
26
Cybin to raise $150 million through private placement
1 month ago
41
BlueSky Wellness scraps merger with Lucy Scientific
1 month ago
40
JAMA article urges more surveillance over ketamine treatments
1 month ago
43
Mynd Life Sciences cuts losses, but faces going concern doubts
1 month ago
67
Atai kicks off DMT Phase 1 study
1 month ago
37
Compass widens Q4 loss as patient hurdles slow trials
1 month ago
76
Braxia Scientific cash dwindles even as revenues rise
1 month ago
65
GH Research pushes forward with DMT trials, drug approvals
1 month ago
61
Red Light Holland loses C$1.2 million in latest quarter
1 month ago
44
Psyence reports no revenue in Q4, but returns a profit
1 month ago
63
Psilocybin treatment beats placebo in Incannex anxiety study
1 month ago
52
Clearmind trials new alcohol disorder fix
1 month ago
67
Enveric sells cannabis patents to focus on psilocin candidates
2 months ago
65
Magic Mushroom Edibles: Everything to Know, from Chocolates to Drops
2 months ago
79
Psilocybin study for bipolar depression encourages more research
2 months ago
53
Prepping the psychedelic industry for MDMA approval
2 months ago
70
Pending Patents: Can Any Company Own Psilocybin?
2 months ago
49
Viridian Capital finds psychedelic stocks typically trade at 3x book
2 months ago
49
Filament Health exports psilocybin to Israel
2 months ago
58
Cybin reports strong cash reserves amid rising R&D costs in Q3
2 months ago
60
Bright Minds trims losses, but deficit grows
2 months ago
65
Doctor sues DEA to treat terminally ill patients with psilocybin
2 months ago
82
Police Officers Are Doing Ayahuasca Now
2 months ago
98
Study finds psychedelic users crowdsource to find ‘trip killers’
2 months ago
75
Study: Police seizures of psilocybin up 369% since 2017
2 months ago
78
Clearmind’s psychedelic portfolio expands with new Chinese patent
2 months ago
84
2024 kicks off with more states drafting psychedelic drug laws
2 months ago
104
Investors rally behind Numinus Wellness in a $6M bought deal
2 months ago
90
Oversubscribed and upsized Alto Neurosciences IPO begins trading today...
2 months ago
81
Numinus Wellness sells its stake in Alto Neurosciences
2 months ago
63
Huxley Health finalizes Sintalica deal, names Bruce Linton as new Chai...
2 months ago
105
Horizons ETFs to close cannabis, psychedelic funds in March
2 months ago
79
Prev.
1
2
3
4
Next
Last
Trending
1.
TikTok ban
2.
Colorado Avalanche
3.
Giannis Antetokounmpo
4.
TSLA
5.
Clippers
6.
Florida Panthers
7.
Rangers
8.
América Pachuca
9.
Timberwolves
10.
Anyone But You
Popular
Therapists Are Unprepared to Talk to People About Taking Psychedelics
What We Know (and Don’t) About Magic Mushroom Paralysis
How To Talk With Your Kids About Psychedelics
Uniform Model Law on Plants and Fungi Medicines: A Better Path to Reregulation
Psychedellux: The Psychedelic Industry News For The Week